Display as
44 items found
Best Practices • 03/19/2024
Resources • 02/12/2024
Resources • 05/29/2023
Best Practices • 03/28/2023
Webinars • 03/24/2023
Webinars • 03/23/2023
Conference Presentations • 12/27/2022
Conference Presentations • 12/27/2022
Conference Presentations • 12/27/2022
Conference Presentations • 12/07/2022
Conference Presentations • 12/07/2022
Conference Presentations • 12/07/2022
Conference Presentations • 11/28/2022
Conference Presentations • 11/28/2022
Conference Presentations • 11/28/2022
Conference Presentations • 11/22/2022
Webinars • 01/27/2022
Webinars • 03/26/2023
Conference Presentations • 12/27/2022
Conference Presentations • 12/27/2022
Conference Presentations • 12/27/2022
Conference Presentations • 12/07/2022
Conference Presentations • 12/07/2022
Conference Presentations • 12/07/2022
Conference Presentations • 11/28/2022
Best Practices • 03/19/2024
Stronger Together uses counseling to increase engagement in and improve the quality of HIV care available for serodiscordant male couples. Through three in-person and additional “booster” sessions over an 18-month period, Stronger Together gave couples a space to work with an HIV professional to improve treatment adherence and keep both people healthy. Stronger Together participants were more likely to adhere to ART than those in a control group.
Resources • 02/12/2024
Online learning portal for clinicians on pre-exposure prophylaxis (PrEP) for prevention of HIV.
Resources • 05/29/2023
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.
Best Practices • 03/28/2023
Nine sites implemented four evidence-based interventions, collectively known as Addressing STIs: Ask.Test.Treat.Repeat. The four intervention components are audio computer-assisted self-interview sexual history taking, patient self-collection of urogenital and extragenital site chlamydia/gonorrhea nucleic acid amplification test specimens, sexual and gender minority welcoming indicators, and provider training, with the overall goal to routinize STI screening, testing, and treatment in primary care. The interventions increased routine STI screening and testing of bacterial STIs based on reported behavioral risk.
Webinars • 03/26/2023
Role of health centers in increasing PrEP access and use among women.
Webinars • 03/24/2023
Review of types of injectable long lasting HIV prevention and treatment medications and their similarities and differences.
Webinars • 03/23/2023
A status neutral approach can create a one door approach for HIV prevention and treatment, which can help normalize both.
Conference Presentations • 12/27/2022
Increasing provider awareness of Pre-exposure prophylaxis (PrEP) in order to improve utilization by people at risk for HIV.
Conference Presentations • 12/27/2022
Review of a 12-month clinical telePrEP program for rural South Carolina residents, which evaluated the feasibility and acceptability of PrEP delivered through a telehealth model.
Conference Presentations • 12/27/2022
Description of a PrEP course's development, using online microlearning modules that can be completed in 10-15 minutes.
Conference Presentations • 12/07/2022
Outline of an approach to HIV pre-exposure prophylaxis (PrEP) in health centers that incorporates and builds upon the strengths of medical and behavioral health clinicians.
Conference Presentations • 12/07/2022
Review of challenges, facilitators, and best practices for routine screening, linkage, and rapid ART in two emergency departments, including during COVID-19.
Conference Presentations • 12/07/2022
Two-part presentation, with Part 1 review of research regarding the efficacy of anal cancer screening and active treatment of HSIL or high-grade squamous intraepithelial lesions in adults with HIV over 35 years old and Part 2 on a multidisciplinary approach to screening and the importance of consumer voices in guiding screening services.
Conference Presentations • 11/28/2022
Review of the epidemiology of STIs, screening and treatment of STIs per the 2021 CDC STI Treatment Guidelines (gonorrhea, chlamydia, syphilis, and Mycoplasma genitalium), and discussion of results from the recent DoxyPEP study and implications for practice.
Conference Presentations • 11/28/2022
Review of PrEP as well as the limitations, challenges and opportunities of current and future PrEP agents and strategies, including long-acting injectable PrEP.
Conference Presentations • 11/28/2022
Review of disparities among persons affected by HIV in the U.S., CDC activities under the four pillars of the the Ending the HIV Epidemic in America Initiative, and the importance of a status neutral syndemic approach for preventing and treating HIV.
Conference Presentations • 11/22/2022
Review of the current status of HIV vaccine development and how mRNA technology may speed the testing of new and existing vaccine concepts.
Webinars • 01/27/2022
Review of the concept of status-neutral and examples of real-world applications from jurisdiction peers and leaders.